AAAAAA

   
Results: 1-10 |
Results: 10
Chlamydia pneumoniae exacerbates aortic inflammatory foci caused by murinecytomegalovirus infection in normocholesterolemic mice
Authors: Burian, K Berencsi, K Endresz, V Gyulai, Z Valyi-Nagy, T Valyi-Nagy, I Bakay, M Geng, YM Virok, D Kari, L Hajnal-Papp, R Trinchieri, G Gonczol, E
Citation: K. Burian et al., Chlamydia pneumoniae exacerbates aortic inflammatory foci caused by murinecytomegalovirus infection in normocholesterolemic mice, CL DIAG LAB, 8(6), 2001, pp. 1263-1266
Optimization of DNA immunization against human cytomegalovirus
Authors: Endresz, V Burian, K Berencsi, K Gyulai, Z Kari, L Horton, H Virok, D Meric, C Plotkin, SA Gonczol, E
Citation: V. Endresz et al., Optimization of DNA immunization against human cytomegalovirus, VACCINE, 19(28-29), 2001, pp. 3972-3980
Chlamydia pneumoniae in atherosclerotic middle cerebral artery
Authors: Virok, D Kis, Z Karai, L Intzedy, L Burian, K Szabo, A Ivanyi, B Gonczol, E
Citation: D. Virok et al., Chlamydia pneumoniae in atherosclerotic middle cerebral artery, STROKE, 32(9), 2001, pp. 1973-1976
A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects
Authors: Berencsi, K Gyulai, Z Gonczol, E Pincus, S Cox, WI Michelson, S Kari, L Meric, C Cadoz, M Zahradnik, J Starr, S Plotkin, S
Citation: K. Berencsi et al., A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects, J INFEC DIS, 183(8), 2001, pp. 1171-1179
Independent and joint effects of antibodies to human heat-shock protein 60and Chlamydia pneumoniae infection in the development of coronary atherosclerosis
Authors: Burian, K Kis, Z Virok, D Endresz, V Prohaszka, Z Duba, J Berencsi, K Boda, K Horvath, L Romics, L Fust, G Gonczol, E
Citation: K. Burian et al., Independent and joint effects of antibodies to human heat-shock protein 60and Chlamydia pneumoniae infection in the development of coronary atherosclerosis, CIRCULATION, 103(11), 2001, pp. 1503-1508
Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-exon4, gB, pp150, and pp28 in healthy individuals: Reevaluation of prevalence of IE1-specific CTLs
Authors: Gyulai, Z Endresz, V Burian, K Pincus, S Toldy, J Cox, WI Meric, C Plotkin, S Gonczol, E Berencsi, K
Citation: Z. Gyulai et al., Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-exon4, gB, pp150, and pp28 in healthy individuals: Reevaluation of prevalence of IE1-specific CTLs, J INFEC DIS, 181(5), 2000, pp. 1537-1546
Chlamydia pneumoniae inhibits apoptosis in human peripheral blood mononuclear cells through induction of IL-10
Authors: Geng, YM Shane, RB Berencsi, K Gonczol, E Zaki, MH Margolis, DJ Trinchieri, G Rook, AH
Citation: Ym. Geng et al., Chlamydia pneumoniae inhibits apoptosis in human peripheral blood mononuclear cells through induction of IL-10, J IMMUNOL, 164(10), 2000, pp. 5522-5529
Roles of interleukin-12 and gamma interferon in murine Chlamydia pneumoniae infection
Authors: Geng, YM Berencsi, K Gyulai, Z Valyi-Nagy, T Gonczol, E Trinchieri, G
Citation: Ym. Geng et al., Roles of interleukin-12 and gamma interferon in murine Chlamydia pneumoniae infection, INFEC IMMUN, 68(4), 2000, pp. 2245-2253
Involvement of a p53-dependent pathway in rubella virus-induced apoptosis
Authors: Megyeri, K Berencsi, K Halazonetis, TD Prendergast, GC Gri, G Plotkin, SA Rovera, G Gonczol, E
Citation: K. Megyeri et al., Involvement of a p53-dependent pathway in rubella virus-induced apoptosis, VIROLOGY, 259(1), 1999, pp. 74-84
A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne)
Authors: Adler, SP Plotkin, SA Gonczol, E Cadoz, M Meric, C Ben Wang, JA Dellamonica, P Best, AM Zahradnik, J Pincus, S Berencsi, K Cox, WI Gyulai, Z
Citation: Sp. Adler et al., A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne), J INFEC DIS, 180(3), 1999, pp. 843-846
Risultati: 1-10 |